RAM

Readystate Asset Management Portfolio holdings

AUM $2.26B
1-Year Est. Return 16.66%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+16.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$207M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
519
New
Increased
Reduced
Closed

Top Buys

1 +$251M
2 +$72.3M
3 +$37.9M
4
SLNO icon
Soleno Therapeutics
SLNO
+$36.7M
5
PAR icon
PAR Technology
PAR
+$15.9M

Sector Composition

1 Healthcare 11.3%
2 Technology 7.13%
3 Consumer Staples 5.19%
4 Consumer Discretionary 3.6%
5 Communication Services 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBAVW
326
M3-Brigade Acquisition V Corp Warrant
MBAVW
$9.63M
$11.5K ﹤0.01%
13,148
+3,098
PAII.WS
327
Pyrophyte Acquisition Corp II Warrants
PAII.WS
$11.3K ﹤0.01%
+28,372
NPACW
328
New Providence Acquisition Corp III Warrants
NPACW
$11K ﹤0.01%
21,700
+11,700
KFIIR
329
K&F Growth Acquisition Corp II Rights
KFIIR
$10.4K ﹤0.01%
65,000
+15,000
DMAAR
330
Drugs Made In America Acquisition Corp Rights
DMAAR
$7.89K ﹤0.01%
50,000
LCCCR
331
Lakeshore Acquisition III Corp Rights
LCCCR
$6.28K ﹤0.01%
25,000
POLEW
332
Andretti Acquisition Corp II Warrant
POLEW
$1.46M
$6.14K ﹤0.01%
23,600
-1,400
MLACR
333
Mountain Lake Acquisition Corp Right
MLACR
$5.95K ﹤0.01%
+24,779
CHPGR
334
ChampionsGate Acquisition Corp Rights
CHPGR
$4.63K ﹤0.01%
25,000
FERAR
335
Fifth Era Acquisition Corp I Rights
FERAR
$4.32K ﹤0.01%
+10,800
AAM.WS
336
DELISTED
AA Mission Acquisition Corp Warrants
AAM.WS
$4.24K ﹤0.01%
25,000
DAICW
337
CID HoldCo Inc Warrants
DAICW
$470K
$4K ﹤0.01%
50,000
HVMCW
338
Highview Merger Corp Warrants
HVMCW
$4.03M
$3.05K ﹤0.01%
+11,290
NAMMW
339
Namib Minerals Warrants
NAMMW
$3.3M
$1.79K ﹤0.01%
25,000
APLS icon
340
Apellis Pharmaceuticals
APLS
$2.57B
-241,977
ADX icon
341
Adams Diversified Equity Fund
ADX
$2.79B
-32,106
AKRO
342
DELISTED
Akero Therapeutics
AKRO
-237,908
ALGS icon
343
Aligos Therapeutics
ALGS
$43M
-203,113
AMLX icon
344
Amylyx Pharmaceuticals
AMLX
$1.52B
-59,132
AOR icon
345
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.31B
-6,120
ASND icon
346
Ascendis Pharma
ASND
$14.8B
-15,570
AXSM icon
347
Axsome Therapeutics
AXSM
$8.3B
-17,860
BA icon
348
Boeing
BA
$182B
0
BBIO icon
349
BridgeBio Pharma
BBIO
$12.7B
-117,379
BBN icon
350
BlackRock Taxable Municipal Bond Trust
BBN
$1.01B
-49,659